KATIE HAYES: Open Payments
NPI 1235686304 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 40 payments from 11 companies in 2025. Trend: 2023 $1,104 · 2024 $1,581 · 2025 $983
Food & beverage: $888Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $249 |
| GENZYME CORPORATION | 4 | $236 |
| ABBVIE INC. | 10 | $156 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $122 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Incyte Corporation | 2 | $47 |
| Amgen Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Organon LLC | 3 | $18 |
Products named: DUPIXENT, TREMFYA, ILUMYA, SKYRIZI, RINVOQ, OTEZLA, COSENTYX, OPZELURA.
Industry payments across WA — which companies pay providers there.
